Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Computerized dynamic pupillometry indices mirrors the heart rate variability parameters.
Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent.
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
Lp(a) lipoprotein: relationship to sinking pre-beta lipoprotein hyperlipoproteinemia, and apolipoprotein B.
The simple design of complement factor H: Looks can be deceiving.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML. N Engl J Med. 2019 10 31; 381(18):1728-1740.
View in:
PubMed
subject areas
Administration, Oral
Adult
Aged
Aged, 80 and over
Aniline Compounds
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Drug Resistance, Neoplasm
Female
fms-Like Tyrosine Kinase 3
Follow-Up Studies
Humans
Leukemia, Myeloid, Acute
Liver
Male
Middle Aged
Mutation
Pyrazines
Recurrence
Remission Induction
Salvage Therapy
Survival Analysis
authors with profiles
Richard A. Larson